ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
4 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
19K
|
6.7M
|
4
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
9 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
19K
|
6.7M
|
9
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
3 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
19K
|
6.7M
|
3
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
18 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
19K
|
6.7M
|
18
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
6 |
14/12/20 |
14/12/20 |
ASX - By Stock
|
19K
|
6.7M
|
6
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
11 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
19K
|
6.7M
|
11
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
rhino78
|
55 |
22K |
4 |
05/12/20 |
05/12/20 |
ASX - By Stock
|
55
|
22K
|
4
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
10 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
19K
|
6.7M
|
10
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
8 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
19K
|
6.7M
|
8
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
21 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
19K
|
6.7M
|
21
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
18 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
19K
|
6.7M
|
18
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Positive IHL-675A in vivo results and FDA Pathway
|
|
rhino78
|
124 |
43K |
12 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
124
|
43K
|
12
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
rhino78
|
237 |
63K |
12 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
237
|
63K
|
12
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
11 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
19K
|
6.7M
|
11
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Strong anti-inflammatory action from IHL-675A
|
|
rhino78
|
157 |
36K |
5 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
157
|
36K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Strong anti-inflammatory action from IHL-675A
|
|
rhino78
|
157 |
36K |
9 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
157
|
36K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Sep20 Quarterly Activities update and Appendix 4C
|
|
rhino78
|
173 |
46K |
12 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
173
|
46K
|
12
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Sep20 Quarterly Activities update and Appendix 4C
|
|
rhino78
|
173 |
46K |
27 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
173
|
46K
|
27
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
13 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
19K
|
6.7M
|
13
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
8 |
11/10/20 |
11/10/20 |
ASX - By Stock
|
19K
|
6.7M
|
8
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Positive Results from IHL-675A (ARDS) in vitro Study
|
|
rhino78
|
320 |
87K |
3 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
320
|
87K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Positive Results from IHL-675A (ARDS) in vitro Study
|
|
rhino78
|
320 |
87K |
4 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
320
|
87K
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Positive Results from IHL-675A (ARDS) in vitro Study
|
|
rhino78
|
320 |
87K |
13 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
320
|
87K
|
13
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
8 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
19K
|
6.7M
|
8
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
10 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
19K
|
6.7M
|
10
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
2 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
603
|
144K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
13 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
603
|
144K
|
13
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
3 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
603
|
144K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
5 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
603
|
144K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
12 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
603
|
144K
|
12
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
2 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
603
|
144K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Options Exercise
|
|
rhino78
|
84 |
19K |
3 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
84
|
19K
|
3
|
|
ASX - By Stock
|
ZMM |
Re:
Ann: Pause in Trading
|
|
rhino78
|
76 |
21K |
2 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
76
|
21K
|
2
|
|
ASX - By Stock
|
ZMM |
Re:
Ann: Pause in Trading
|
|
rhino78
|
76 |
21K |
6 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
76
|
21K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Options exercise
|
|
rhino78
|
43 |
8.3K |
9 |
06/09/20 |
06/09/20 |
ASX - By Stock
|
43
|
8.3K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Positive Results from IHL-675A (ARDS) in vitro Study
|
|
rhino78
|
320 |
87K |
15 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
320
|
87K
|
15
|
|
ASX - By Stock
|
IHL |
Re:
Dr Sud Speaks
|
|
rhino78
|
72 |
20K |
5 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
72
|
20K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
1 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
19K
|
6.7M
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Top 20 reveals significant buyer
|
|
rhino78
|
36 |
15K |
5 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
36
|
15K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Annual Report
|
|
rhino78
|
6 |
2.6K |
5 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
6
|
2.6K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
6 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
19K
|
6.7M
|
6
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
11 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
19K
|
6.7M
|
11
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
7 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
603
|
144K
|
7
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
7 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
603
|
144K
|
7
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
5 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
603
|
144K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
1 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
603
|
144K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
options
|
|
rhino78
|
603 |
144K |
8 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
603
|
144K
|
8
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.7M |
4 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
19K
|
6.7M
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
rhino78
|
34 |
10K |
16 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
34
|
10K
|
16
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
rhino78
|
34 |
10K |
12 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
34
|
10K
|
12
|
|